MA09.07 Phase I Trial of in situ Vaccination with CCL21 Gene-Modified DC Induces Specific Systemic Immune Response and Tumor Infiltrating CD8+ T Cells

Authors :: William D. Wallace
Fereidoun Abtin
David Elashoff
Paul C. Tumeh
Sharon Adams
Jonathan W. Goldman
Frances Rosen
Edward B. Garon
Dörthe Schaue
Felicita Baratelli
Gerald Wang
Jay Lee
Gang Zeng
Francesco M. Marincola
Mi-Heon Lee
Sherven Sharma
Jane Yanagawa
Ying Lin
Steven M. Dubinett
Tonya C. Walser
Karen L. Reckamp
Robert D. Suh
Source :: Journal of Thoracic Oncology. 12:S395
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Pulmonary and Respiratory Medicine
Vaccination
In situ
Immune system
Oncology
business.industry
Immunology
Medicine
Cytotoxic T cell
business
Gene
CCL21

Full Text Access

Tools